5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway

Background: Our previous study found that 5-Aza-2′-deoxycytidine (5-Aza-CdR) can repress the expression and activity of protein serine/threonine phosphatase-1γ (PP1γ) in mouse hippocampus. It is well known that PP1γ regulates cell metabolism, which is related to hypoxia/ischaemia tolerance. It has b...

Full description

Bibliographic Details
Main Authors: Ruifang Qi, Xiaolu Zhang, Yabin Xie, Shuyuan Jiang, You Liu, Xiaolei Liu, Wei Xie, Xiaoe Jia, Rengui Bade, Ruili Shi, Sijie Li, Changhong Ren, Kerui Gong, Chunyang Zhang, Guo Shao
Format: Article
Language:English
Published: Elsevier 2019-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332219319250
id doaj-0c8ef8726cd24c4d971ad6dbd3ac1be4
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Ruifang Qi
Xiaolu Zhang
Yabin Xie
Shuyuan Jiang
You Liu
Xiaolei Liu
Wei Xie
Xiaoe Jia
Rengui Bade
Ruili Shi
Sijie Li
Changhong Ren
Kerui Gong
Chunyang Zhang
Guo Shao
spellingShingle Ruifang Qi
Xiaolu Zhang
Yabin Xie
Shuyuan Jiang
You Liu
Xiaolei Liu
Wei Xie
Xiaoe Jia
Rengui Bade
Ruili Shi
Sijie Li
Changhong Ren
Kerui Gong
Chunyang Zhang
Guo Shao
5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway
Biomedicine & Pharmacotherapy
Autophagy
5-Aza-2′-deoxycytidine
Hypoxia tolerance
TSC1
author_facet Ruifang Qi
Xiaolu Zhang
Yabin Xie
Shuyuan Jiang
You Liu
Xiaolei Liu
Wei Xie
Xiaoe Jia
Rengui Bade
Ruili Shi
Sijie Li
Changhong Ren
Kerui Gong
Chunyang Zhang
Guo Shao
author_sort Ruifang Qi
title 5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway
title_short 5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway
title_full 5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway
title_fullStr 5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway
title_full_unstemmed 5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway
title_sort 5-aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the tsc1/mtor pathway
publisher Elsevier
series Biomedicine & Pharmacotherapy
issn 0753-3322
publishDate 2019-10-01
description Background: Our previous study found that 5-Aza-2′-deoxycytidine (5-Aza-CdR) can repress the expression and activity of protein serine/threonine phosphatase-1γ (PP1γ) in mouse hippocampus. It is well known that PP1γ regulates cell metabolism, which is related to hypoxia/ischaemia tolerance. It has been reported that it can also induce autophagy in cancer cells. Autophagy is important for maintaining cellular homeostasis associated with metabolism. In this study, we examined whether 5-Aza-CdR increases hypoxia tolerance-dependent autophagy by initiating the TSC1/mTOR/autophagy signalling pathway in neuronal cells. Methods: 5-Aza-CdR was either administered to mice via intracerebroventricular injection (i.c.v) or added to cultured hippocampal-derived neuronal cell line (HT22 cell) in the medium for cell culture. The hypoxia tolerance of mice was measured by hypoxia tolerance time and Perl's iron stain. The mRNA and protein expression levels of tuberous sclerosis complex 1 (TSC1), mammalian target of rapamycin (mTOR) and autophagy marker light chain 3 (LC3) were measured by real-time PCR and western blot. The p-mTOR and p-p70S6k proteins were used as markers for mTOR activity. In addition, the role of autophagy was determined by correlating its intensity with hypoxia tolerance in a time-dependent manner. At the same time, the involvement of the TSC1/mTOR pathway in autophagy was also examined through transfection with TSC1 (hamartin) plasmid. Results: 5-Aza-CdR was revealed to increase hypoxia tolerance and induce autophagy, accompanied by an increase in mRNA and protein expression levels of TSC1, reduction in p-mTOR (Ser2448) and p-p70S6k (Thr389) protein levels, and an increase in the ratio of LC3-II/LC3-I in both mouse hippocampus and hippocampal-derived neuronal cell line (HT22). The fluorescence intensity of hamartin was enhanced in the hippocampus of mice exposed to 5-Aza-CdR. Moreover, HT22 cells that over-expressed TSC1 showed more autophagy. Conclusions: 5-Aza-CdR can increase hypoxia tolerance by inducing autophagy by initiating the TSC1/mTOR pathway.
topic Autophagy
5-Aza-2′-deoxycytidine
Hypoxia tolerance
TSC1
url http://www.sciencedirect.com/science/article/pii/S0753332219319250
work_keys_str_mv AT ruifangqi 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT xiaoluzhang 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT yabinxie 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT shuyuanjiang 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT youliu 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT xiaoleiliu 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT weixie 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT xiaoejia 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT renguibade 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT ruilishi 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT sijieli 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT changhongren 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT keruigong 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT chunyangzhang 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
AT guoshao 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway
_version_ 1721432943340027904
spelling doaj-0c8ef8726cd24c4d971ad6dbd3ac1be42021-05-21T04:17:33ZengElsevierBiomedicine & Pharmacotherapy0753-33222019-10-011185-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathwayRuifang Qi0Xiaolu Zhang1Yabin Xie2Shuyuan Jiang3You Liu4Xiaolei Liu5Wei Xie6Xiaoe Jia7Rengui Bade8Ruili Shi9Sijie Li10Changhong Ren11Kerui Gong12Chunyang Zhang13Guo Shao14Department of Neurobiology and Center of Stroke, Beijing Institute for Brain Disorders, School of Basic Medical Science, Capital Medical University, Beijing, China; Inner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaBeijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaBeijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaDepartment of Oral and Maxillofacial Surgery, University of California San Francisco, San Francisco, USADepartment of neurosurgery, the First Affiliated Hospital of Baotou Medical College, Inner Mongolia, ChinaDepartment of Neurobiology and Center of Stroke, Beijing Institute for Brain Disorders, School of Basic Medical Science, Capital Medical University, Beijing, China; Inner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China; Corresponding author at: Department of Neurobiology and Center of Stroke, Beijing Institute for Brain Disorders, School of Basic Medical Science, Capital Medical University, Beijing, China.Background: Our previous study found that 5-Aza-2′-deoxycytidine (5-Aza-CdR) can repress the expression and activity of protein serine/threonine phosphatase-1γ (PP1γ) in mouse hippocampus. It is well known that PP1γ regulates cell metabolism, which is related to hypoxia/ischaemia tolerance. It has been reported that it can also induce autophagy in cancer cells. Autophagy is important for maintaining cellular homeostasis associated with metabolism. In this study, we examined whether 5-Aza-CdR increases hypoxia tolerance-dependent autophagy by initiating the TSC1/mTOR/autophagy signalling pathway in neuronal cells. Methods: 5-Aza-CdR was either administered to mice via intracerebroventricular injection (i.c.v) or added to cultured hippocampal-derived neuronal cell line (HT22 cell) in the medium for cell culture. The hypoxia tolerance of mice was measured by hypoxia tolerance time and Perl's iron stain. The mRNA and protein expression levels of tuberous sclerosis complex 1 (TSC1), mammalian target of rapamycin (mTOR) and autophagy marker light chain 3 (LC3) were measured by real-time PCR and western blot. The p-mTOR and p-p70S6k proteins were used as markers for mTOR activity. In addition, the role of autophagy was determined by correlating its intensity with hypoxia tolerance in a time-dependent manner. At the same time, the involvement of the TSC1/mTOR pathway in autophagy was also examined through transfection with TSC1 (hamartin) plasmid. Results: 5-Aza-CdR was revealed to increase hypoxia tolerance and induce autophagy, accompanied by an increase in mRNA and protein expression levels of TSC1, reduction in p-mTOR (Ser2448) and p-p70S6k (Thr389) protein levels, and an increase in the ratio of LC3-II/LC3-I in both mouse hippocampus and hippocampal-derived neuronal cell line (HT22). The fluorescence intensity of hamartin was enhanced in the hippocampus of mice exposed to 5-Aza-CdR. Moreover, HT22 cells that over-expressed TSC1 showed more autophagy. Conclusions: 5-Aza-CdR can increase hypoxia tolerance by inducing autophagy by initiating the TSC1/mTOR pathway.http://www.sciencedirect.com/science/article/pii/S0753332219319250Autophagy5-Aza-2′-deoxycytidineHypoxia toleranceTSC1